JPMorgan initiated coverage of Blueprint Medicines (BPMC) with an Overweight rating and $126 price target Blueprint is a biotech company ...
JP Morgan initiated coverage on Blueprint Medicines Corporation (NASDAQ:BPMC), a biotech company focused on modulating immune ...
Discover how Democracy Forward is preparing to challenge President-elect Donald Trump's second-term agenda with a large-scale ...
Greetings and welcome to the Vuzix third quarter for the period ending September 30th, 2024 financial results and business ...
Many scientists at the federal health agencies await the second Donald Trump administration with dread as well as uncertainty over how the president-elect will reconcile starkly different philosophies ...
Jacobin on MSN17h
Four Myths About Kamala Harris’s LossIn assessing Donald Trump’s victory, pundits have claimed the country turned right, the Harris campaign was too far left and ...
Bitcoin has crossed $90,000 for the first time ever as its record rally continues in the wake of President-elect Donald Trump’s victory. Galaxy Digital Founder and CEO Mike Novogratz says the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback